Apoptosis of Blood Dendritic Cells in Breast Cancer Patients
Author Information
Author(s): Pinzon-Charry Alberto, Maxwell Tammy, McGuckin Michael A, Schmidt Chris, Furnival Colin, López J Alejandro
Primary Institution: Queensland Institute of Medical Research
Hypothesis
Tumor products induce apoptosis in blood dendritic cells (DCs) in patients with breast cancer.
Conclusion
The study shows that blood dendritic cells in breast cancer patients undergo spontaneous apoptosis, which can be mitigated by ex vivo conditioning.
Supporting Evidence
- Patients with breast cancer had a higher proportion of apoptotic blood dendritic cells compared to healthy volunteers.
- Tumor-derived supernatants induced apoptosis in blood dendritic cells.
- CD40 stimulation protected blood dendritic cells from apoptosis.
Takeaway
In patients with breast cancer, more blood cells that help fight infections and tumors are dying than in healthy people, but we can help keep them alive with certain treatments.
Methodology
The study assessed apoptosis in blood dendritic cells using Annexin-V and TUNEL assays on peripheral blood mononuclear cells from patients and healthy volunteers.
Participant Demographics
13 female patients aged 40 to 75 with early stage breast cancer and 15 healthy female volunteers aged 24 to 73.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website